WHO Releases First Global Guidelines for Meningitis Diagnosis, Treatment, and Care

Geneva, Switzerland — In a major step towards defeating meningitis worldwide, the World Health Organization (WHO) has unveiled its first-ever global guidelines on the diagnosis, treatment, and long-term care of the disease. The comprehensive guidelines aim to improve early detection, ensure timely treatment, and enhance post-recovery support for individuals affected by meningitis, particularly in low- and middle-income countries.

Meningitis, particularly its bacterial form, poses a serious global health threat and can become fatal within 24 hours. WHO estimates that around 20% of those who survive bacterial meningitis suffer long-term complications, such as hearing loss, cognitive impairment, or physical disability.

“Bacterial meningitis kills one in six of the people it strikes, and leaves many others with lasting health challenges,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus during the launch. “Implementing these new guidelines will help save lives, improve long-term care for those affected by meningitis, and strengthen health systems.”

Despite the availability of vaccines and effective treatments for certain strains of the disease, meningitis continues to burden families, communities, and health systems—especially in the African “meningitis belt,” a region prone to recurrent large-scale epidemics.

The newly launched guidelines offer detailed, evidence-based recommendations for the clinical management of acute community-acquired meningitis in children over one month old, adolescents, and adults. They address both bacterial and viral forms of the disease and are designed for use in a wide range of healthcare settings, including emergency rooms, inpatient and outpatient facilities.

The guidelines encompass every stage of care: from diagnosis and antibiotic therapy to adjunctive and supportive treatments, as well as the management of long-term effects. Importantly, they include recommendations tailored for both epidemic and non-epidemic situations—replacing the previous 2014 WHO outbreak response guidance.

Given the disproportionate impact of meningitis in low-resource settings, the guidelines are specifically developed for implementation in low- and middle-income countries. They serve as a vital resource for healthcare workers, policymakers, educators, and civil society organisations engaged in capacity-building, health education, and research.

This initiative is part of the broader “Defeating Meningitis by 2030” Global Roadmap, which was adopted by WHO Member States in 2020. The roadmap sets ambitious targets: eliminating bacterial meningitis epidemics, cutting vaccine-preventable cases by 50%, reducing deaths by 70%, and improving quality of life for survivors.

As the WHO rolls out these guidelines globally, the organisation is calling on countries to integrate them into national health policies and strengthen systems to combat meningitis more effectively and equitably